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Background
Human leukocyte antigen (HLA)-B*13:01 and HLA-
C*03:04, which have recently been reported to be strongly
associated with dapson-induced DIHS/DRESS in patients
suffering from leprosy in China.
Observation
A 38-year old Japanese woman visited our dermatological
department on June 24, 2013, with a three-day history of
erythematous lesions on the trunk and extremities. She
had been treated orally with 50 mg of diaminodiphenyl
sulfone (dapson) daily for pityriasis lichenoides et varioli-
formis acuta (PLEVA) for 38 days. Physical examination
on admission revealed fever (38.4℃), bilateral cervical
lymphadenopathy, facial edema with erythema, and round
erythematous and purpuric plaques on the trunk and
extremities. Erythematous targetoid lesions were also
found. Blood examination revealed an increased white
blood cell count (13.4 ~ 109/l: normal 3.5-9 ~ 109/l), and
mild liver dysfunction (alanine aminotransferase; 40 IU/l :
normal 5-25 IU/l). A skin biopsy obtained from the
patient’s abdomen revealed acanthosis, hydropic and
vacuolar degeneration of epidermal basal cells and
upper dermal infiltration consisting of lymphocytes and
neutrophils. No extensive epidermal necrosis was found. A
lymphocyte transformation test (LTT) for dapson was
positive (stimulation index (SI) = 5.3, cut-off for LTT, SI =
1.8). These findings fulfilled the criteria for drug-induced
hypersensitivity syndrome (DIHS)/drug reaction with eosi-
nophilia and systemic symptoms (DRESS), and dapson
therapy was discontinued. The patient was started on a
course of systemic prednisolone (1.0 mg/kg daily). The
dose was tapered over the next 70 days in line with the
improvement of clinical symptoms. Both human herpes-
virus-6 and cytomegalovirus reactivation had not been
seen during the course. Human leukocyte antigen
(HLA)-B*13:01 and HLA-C*03:04 were identified in this
patient.
Conclusion
Our examination indicated that these HLA alleles are not
only related to DIHS/DRESS in patients with leprosy
treated with dapson, but also to DIHS/DRESS in patients
treated with dapson for other inflammatory diseases
including PLEVA.
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